Table 5.

Dynamics of MHC-I and MHC-II molecules in spleen lymphocytes.

Marker (%)	Time point	Groups (n = 5)
		Blank	PBS	Adjuvant	rTgEF-1α
MHC-I	Week 0	18.19 ± 2.46	17.17 ± 2.62	18.06 ± 1.54	18.01 ± 2.23
	Week 2	16.55 ± 2.15	17.13 ± 1.91	18.17 ± 2.31	24.28 ± 3.29∗∗
	Week 4	17.64 ± 1.82	18.02 ± 1.91	18.22 ± 1.76	29.16 ± 3.43∗∗
	Week 6	17.88 ± 1.78	17.76 ± 1.16	18.34 ± 2.40	30.47 ± 3.15∗∗
MHC-II	Week 0	3.07 ± 0.97	2.88 ± 0.37	3.22 ± 0.62	3.16 ± 0.54
	Week 2	2.99 ± 0.71	3.17 ± 0.38	3.13 ± 0.79	3.44 ± 0.96
	Week 4	3.25 ± 0.45	3.17 ± 0.38	3.04 ± 0.46	6.78 ± 1.48∗∗
	Week 6	3.22 ± 0.56	3.11 ± 0.73	3.05 ± 0.61	7.96 ± 1.37∗∗

Data are presented as the mean ± SD (n = 5). ^∗∗represents statistically highly significant difference (P < 0.01) as compared with control groups: Blank (unvaccinated control), PBS and Adjuvant group.